在小儿固体瘤患者中使用Romiplostim治疗与治疗相关的血小板缺血的单一机构经验
Melanie D Degliuomini1, Katherine Armstrong1, Michael Curry2
1Department of Pediatrics, Hackensack University Medical Center, Hackensack, New Jersey, USA.
Pediatric blood & cancer
|August 29, 2025
概括
像罗米普洛司姆这样的血栓形成素受体激动剂 (TPO-RA) 可以在儿童癌症患者中安全治疗化疗诱导的血栓缩症 (CIT). 需要进一步的研究来确认romiplostim
科学领域:
- 癌症学
- 血液学
- 儿童医学
背景情况:
- 化疗引起的血小板减少 (CIT) 是癌症患者常见的不良反应.
- 可能需要降低化疗剂量,增加血小板输血的必要性.
- 关于用于小儿CIT的血栓形成素受体激动剂 (TPO-RA) 的数据有限.
研究的目的:
- 评估罗米普洛司姆在患有固体瘤的儿科患者的安全性和疗效.
- 评估romiplostim在特定患者群体中的临床益处.
主要方法:
- 一个单一机构的回顾性研究设计.
- 包括正在接受癌症治疗的固体瘤儿科患者.
- 评估罗米普洛司姆的使用情况和患者的治疗结果.
主要成果:
- 儿科患者观察到Romipostim的耐受性很好.
- 这种药物似乎为治疗CIT提供了临床益处.
- 在研究期间没有报告任何重大安全问题.
结论:
- 作为儿童癌症患者的安全和潜在有效治疗方法,Romipostim具有前景.
- 需要进行进一步的临床试验,以确定TPO-RA作为儿科CIT的治疗标准.
- 这项研究支持儿童瘤学中TPO-RA的研究.
相关概念视频
Stem Cell Therapy for Tissue Regeneration
4.2K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.2K
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Bone Marrow Sampling and Transplants
493
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
493
Tumor Immunotherapy
659
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
659
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
264
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
264


